Vitamin D Deficiency in Older Patients-Problems of Sarcopenia, Drug Interactions, Management in Deficiency
- PMID: 33920130
- PMCID: PMC8069639
- DOI: 10.3390/nu13041247
Vitamin D Deficiency in Older Patients-Problems of Sarcopenia, Drug Interactions, Management in Deficiency
Abstract
Vitamin D deficiency frequently occurs in older people, especially in individuals with comorbidity and polypharmacotherapy. In this group, low vitamin D plasma concentration is related to osteoporosis, osteomalacia, sarcopenia and myalgia. Vitamin D levels in humans is an effect of the joint interaction of all vitamin D metabolic pathways. Therefore, all factors interfering with individual metabolic stages may affect 25-hydroxyvitamin D plasma concentration. The known factors affecting vitamin D metabolism interfere with cytochrome CYP3A4 activity. There is another group of factors that impairs intestinal vitamin D absorption. The phenomenon of drugs and vitamin D interactions is observed first and foremost in patients with comorbidity. This is a typical situation, where the absence of "hard evidence" is not synonymous with the possible lack of adverse effects. Osteoporosis and sarcopenia (generalized and progressive decrease of skeletal muscle mass and strength) are some of the musculoskeletal consequences of hypovitaminosis D. These consequences are related to an increased risk of adverse outcomes, including bone fractures, physical disabilities, and a lower quality of life. This can lead not only to an increased risk of falls and fractures but is also one of the main causes of frailty syndrome in the aging population. Generally, Vitamin D plasma concentration is significantly lower in subjects with osteoporosis and muscle deterioration. In some observational and uncontrolled treatment studies, vitamin D supplementation resulted in a reduction of proximal myopathy and muscle pain. The most conclusive results were found in subjects with severe vitamin D deficiency and in patients avoiding large doses of vitamin D. However, the role of vitamin D in muscle pathologies is not clear and research has provided conflicting results. This is plausibly due to the heterogeneity of the subjects, vitamin D doses and environmental factors. This report presents data on some problems with vitamin D deficiency in the elderly population and the management of vitamin D deficiency D in successful or unsuccessful aging.
Keywords: deficiency; drug interaction; elderly; sarcopenia; supplementation; treatment; vitamin D.
Conflict of interest statement
The authors declare no conflict of interest
Similar articles
-
Vitamin D and osteosarcopenia: an update from epidemiological studies.Curr Opin Clin Nutr Metab Care. 2017 Nov;20(6):498-503. doi: 10.1097/MCO.0000000000000411. Curr Opin Clin Nutr Metab Care. 2017. PMID: 28806178 Free PMC article.
-
Low vitamin D status is associated with reduced muscle mass and impaired physical performance in frail elderly people.Eur J Clin Nutr. 2013 Oct;67(10):1050-5. doi: 10.1038/ejcn.2013.144. Epub 2013 Aug 14. Eur J Clin Nutr. 2013. PMID: 23942175
-
Vitamin D supplementation and muscle strength in pre-sarcopenic elderly Lebanese people: a randomized controlled trial.Arch Osteoporos. 2018 Dec 19;14(1):4. doi: 10.1007/s11657-018-0553-2. Arch Osteoporos. 2018. PMID: 30569340 Clinical Trial.
-
Relevance of vitamin D in the pathogenesis and therapy of frailty.Curr Opin Clin Nutr Metab Care. 2017 Jan;20(1):26-29. doi: 10.1097/MCO.0000000000000334. Curr Opin Clin Nutr Metab Care. 2017. PMID: 27749712 Review.
-
Calcium and vitamin D nutrition and bone disease of the elderly.Public Health Nutr. 2001 Apr;4(2B):547-59. doi: 10.1079/phn2001140. Public Health Nutr. 2001. PMID: 11683549 Review.
Cited by
-
Associations of Serum Vitamin D with Sarcopenia in Patients with Chronic Liver Disease: A Population-Based Cross-Sectional Study.Calcif Tissue Int. 2025 May 5;116(1):69. doi: 10.1007/s00223-025-01376-8. Calcif Tissue Int. 2025. PMID: 40325227
-
Insights into Pathogenesis, Nutritional and Drug Approach in Sarcopenia: A Systematic Review.Biomedicines. 2023 Jan 5;11(1):136. doi: 10.3390/biomedicines11010136. Biomedicines. 2023. PMID: 36672642 Free PMC article. Review.
-
Role of Vitamin D in Cognitive Dysfunction: New Molecular Concepts and Discrepancies between Animal and Human Findings.Nutrients. 2021 Oct 20;13(11):3672. doi: 10.3390/nu13113672. Nutrients. 2021. PMID: 34835929 Free PMC article. Review.
-
High Prevalence of Energy and Nutrients Inadequacy among Brazilian Older Adults.Nutrients. 2023 Jul 21;15(14):3246. doi: 10.3390/nu15143246. Nutrients. 2023. PMID: 37513664 Free PMC article.
-
Nutrients against Glucocorticoid-Induced Muscle Atrophy.Foods. 2022 Feb 25;11(5):687. doi: 10.3390/foods11050687. Foods. 2022. PMID: 35267320 Free PMC article. Review.
References
-
- Weaver C.M., Alexander D.D., Boushey C.J., Dawson-Hughes B., Lappe J.M., LeBoff M.S., Liu S., Looker A.C., Wallace T.C., Wang D.D. Calcium plus vitamin D supplementation and risk of fractures: An updated meta-analysis from the National Osteoporosis Foundation. Osteoporos. Int. 2016;27:367–376. doi: 10.1007/s00198-015-3386-5. - DOI - PMC - PubMed
-
- Pludowski P., Holick M.F., Pilz S., Wagner C.L., Hollis B.W., Grant W.B., Shoenfeld Y., Lerchbaum E., Llewellyn D.J., Kienreich K., et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality—A review of recent evidence. Autoimmun. Rev. 2013;12:976–989. doi: 10.1016/j.autrev.2013.02.004. - DOI - PubMed
-
- Autier P., Mullie P., Macacu A., Dragomir M., Boniol M., Coppens K., Pizot C., Boniol M. Effect of vitamin D supplementation on non-skeletal disorders: A systematic review of meta-analyses and randomised trials. Lancet Diabetes Endocrinol. 2017;5:986–1004. doi: 10.1016/S2213-8587(17)30357-1. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical